Literature DB >> 28990139

Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma.

Ji Y Park1,2, Daegy Hong3, Ji Young Park4.   

Abstract

In endometrial endometrioid adenocarcinoma (EEC), the depth of myometrial invasion (MI) is an important parameter for determining whether additional treatment is warranted. The present study investigated the association between MI patterns, cancer stem cell (CSC) phenotypes, and their clinicopathological significance in EEC. A total of 73 cases of EEC with MI were examined in this study. Haematoxylin and eosin-stained tissue specimens were analysed for MI pattern, which was categorised as infiltrating; expansile; adenomyosis (AM)-like; or microcystic, elongated, and fragmented (MELF)-type. The expression of CSC markers such as cluster of differentiation (CD)44, CD133, and Nanog1, as well as oestrogen receptor (ER) and progesterone receptor (PR) was examined by immunohistochemistry. Clinicopathological features including age, DOI, MI pattern, LVI, lymph node (LN) metastasis, disease progression, and survival outcome were recorded. Most examined cases (45/73) were International Federation of Gynecology and Obstetrics (FIGO) stage I. MI showed infiltrating (49.3%), AM-like (26.3%), MELF (15.1%), and expansile (9.6%) patterns. Tumours with the infiltrating pattern were associated with high FIGO grade (P = 0.002), reduced ER and PR, and CD44 expression (P = 0.014, 0.026, and 0.030, respectively); those with a MELF pattern showed LN metastasis (P < 0.001), lymphovascular invasion (P = 0.011), and reduced ER, CD44, and CD133 expression (P = 0.036, 0.006, and 0.016, respectively). EEC with infiltrating/MELF patterns of MI is associated with worse prognosis. These results suggest that CSC expression profiles are an unfavourable indicator of EEC.

Entities:  

Keywords:  Cancer stem cell marker; Endometrioid carcinoma; Epithelial-to-mesenchymal transition; Myometrial invasion

Mesh:

Substances:

Year:  2017        PMID: 28990139     DOI: 10.1007/s12253-017-0320-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  34 in total

1.  Loss of progesterone receptor may lead to an invasive phenotype in human endometrial cancer.

Authors:  E E Hanekamp; E C M Kühne; E Smid-Koopman; P E de Ruiter; S Chadha-Ajwani; A O Brinkmann; C W Burger; J A Grootegoed; F J M Huikeshoven; L J Blok
Journal:  Eur J Cancer       Date:  2002-11       Impact factor: 9.162

Review 2.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins.

Authors:  Eline E Hanekamp; Susanne C J P Gielen; Petra E De Ruiter; Savi Chadha-Ajwani; Frans J Huikeshoven; Curt W Burger; J Anton Grootegoed; Leen J Blok
Journal:  J Soc Gynecol Investig       Date:  2005-05

Review 5.  Putting tumours in context.

Authors:  M J Bissell; D Radisky
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

6.  Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors.

Authors:  Donghai Dai; Douglas M Wolf; Elizabeth S Litman; Michael J White; Kimberly K Leslie
Journal:  Cancer Res       Date:  2002-02-01       Impact factor: 12.701

7.  Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.

Authors:  Paul P Szotek; Rafael Pieretti-Vanmarcke; Peter T Masiakos; Daniela M Dinulescu; Denise Connolly; Rosemary Foster; David Dombkowski; Frederic Preffer; David T Maclaughlin; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-18       Impact factor: 11.205

8.  Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1).

Authors:  N Zagorianakou; E Ioachim; A Mitselou; E Kitsou; P Zagorianakou; S Stefanaki; G Makrydimas; N J Agnantis
Journal:  Eur J Gynaecol Oncol       Date:  2003       Impact factor: 0.196

9.  Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.

Authors:  Shawn K Murray; Robert H Young; Robert E Scully
Journal:  Int J Gynecol Pathol       Date:  2003-10       Impact factor: 2.762

10.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  6 in total

1.  Clinicopathological and Molecular Differences Between Gastric-type Mucinous Carcinoma and Usual-type Endocervical Adenocarcinoma of the Uterine Cervix.

Authors:  Hera Jung; Go Eun Bae; Hye Min Kim; Hyun-Soo Kim
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

2.  Clinicopathologic Association and Prognostic Value of MELF Pattern in Invasive Endocervical Adenocarcinoma (ECA) as Classified by IECC.

Authors:  Sheila E Segura; Lien Hoang; Monica Boros; Cristina Terinte; Anna Pesci; Sarit Aviel-Ronen; Takako Kiyokawa; Isabel Alvarado-Cabrero; Esther Oliva; Kay J Park; Robert A Soslow; Simona Stolnicu
Journal:  Int J Gynecol Pathol       Date:  2020-09       Impact factor: 3.326

3.  Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma.

Authors:  Ignacio Ruz-Caracuel; Jorge L Ramón-Patino; Álvaro López-Janeiro; Laura Yébenes; Alberto Berjón; Alicia Hernández; Alejandro Gallego; Victoria Heredia-Soto; Marta Mendiola; Andrés Redondo; Alberto Peláez-García; David Hardisson
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639

4.  The Diminishment of Novel Endometrial Carcinoma-Derived Stem-like Cells by Targeting Mitochondrial Bioenergetics and MYC.

Authors:  Laureen P Helweg; Beatrice A Windmöller; Leonie Burghardt; Jonathan Storm; Christine Förster; Nils Wethkamp; Ludwig Wilkens; Barbara Kaltschmidt; Constanze Banz-Jansen; Christian Kaltschmidt
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

Review 5.  Bone Marrow-Derived Cells in Endometrial Cancer Pathogenesis: Insights from Breast Cancer.

Authors:  Alejandra I Ferrer; Ella Einstein; Sara S Morelli
Journal:  Cells       Date:  2022-02-17       Impact factor: 6.600

6.  L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma.

Authors:  Damiano Arciuolo; Antonio Travaglino; Angela Santoro; Giulia Scaglione; Nicoletta D'Alessandris; Michele Valente; Frediano Inzani; Rossella Accarino; Alessia Piermattei; Roberta Benvenuto; Antonio Raffone; Camilla Nero; Silvia Pelligra; Francesco Fanfani; Massimo Mascolo; Gian Franco Zannoni
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.